Progress in Drug Research
Hepatitis C virus (HCV) was first identified in 1989 as the etiologic agent of non-A, non-B hepatitis [1] and is currently recognized as the leading cause of chronic liver disease worldwide. In contrast to hepatitis B virus infection, in which only about 5% of adult infections become chronic, more t...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Basel
Birkhäuser
2000, 2000
|
| Edition: | 1st ed. 2000 |
| Series: | Progress in Drug Research
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- Recent advances in prevention and treatment of hepatitis C virus infections
- The effects of morphine on cell proliferation
- Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey
- Multi-dimensional QSAR in drug research
- NMR spectroscopy in drug discovery: Tools for combinatorial chemistry, natural products, and metabolism research
- Prostate cancer and the androgen receptor: Strategies for the development of novel therapeutics
- Quantitative structure-activity relationships of cardiotonic agents
- Index Vol. 55
- Index of titles, Vol. 1-55
- Author and paper index, Vol. 1-55